ciprofloxacin
NDC 16571-413, ciprofloxacin, tablet, film coated, from Rising Pharma Holdings, Inc..
- Product NDC
- 16571-413
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076639
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16571-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CIPROFLOXACIN HYDROCHLORIDE750 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inhibitors [MoA]; Fluoroquinolone Antibacterial [EPC]; Fluoroquinolones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16571-413-05 | 16571041305 | 50 TABLET, FILM COATED in 1 BOTTLE (16571-413-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ef468722-68cd-440b-afd7-2285029db41fNADAC price for package 16571041305
GET /v1/drugs/nadac/16571041305
Use it
Look up 16571-413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16571-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16571-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.